{"entity":{"type":"insider","cik":"0001292636","url":"/insider/0001292636","json_url":"/insider/0001292636.json","name":"Tierney David S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":20,"first":"2006-02-02","last":"2025-08-28","span_basis":"filed_date"},"name_variants":[{"name":"Tierney David S","source":"filing","n_filings":20,"first_seen":"2006-02-02","last_seen":"2025-08-28"}],"transactions":[{"id":4229165,"accession":"0001161697-25-000302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000302","line_url":"/filing/0001161697-25-000302#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26000.0,"shares_display":"26,000","price_per_share":20.2,"price_display":"20.20","price_state":"stated","total_value":525200.0,"total_display":"525,200.00","total_whole":"525,200","shares_owned_after":379620.0,"shares_owned_after_display":"379,620","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-27","filed_date":"2025-08-28","scope":"insider"},{"id":2886899,"accession":"0001161697-24-000375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000375","line_url":"/filing/0001161697-24-000375#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.097,"price_display":"20.10","price_state":"stated","total_value":301455.0,"total_display":"301,455.00","total_whole":"301,455","shares_owned_after":348874.0,"shares_owned_after_display":"348,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-21","filed_date":"2024-08-23","scope":"insider"},{"id":2584578,"accession":"0001161697-24-000194","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-24-000194","line_url":"/filing/0001161697-24-000194#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":392000.0,"total_display":"392,000.00","total_whole":"392,000","shares_owned_after":348874.0,"shares_owned_after_display":"348,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-10","scope":"insider"},{"id":8246838,"accession":"0001161697-23-000623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-23-000623","line_url":"/filing/0001161697-23-000623#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":13.325,"price_display":"13.32","price_state":"stated","total_value":666250.0,"total_display":"666,250.00","total_whole":"666,250","shares_owned_after":333541.0,"shares_owned_after_display":"333,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-14","scope":"insider"},{"id":8650631,"accession":"0001161697-23-000243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-23-000243","line_url":"/filing/0001161697-23-000243#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":16.83,"price_display":"16.83","price_state":"stated","total_value":504900.0,"total_display":"504,900.00","total_whole":"504,900","shares_owned_after":313541.0,"shares_owned_after_display":"313,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-05","filed_date":"2023-04-07","scope":"insider"},{"id":7876358,"accession":"0001437749-23-006276","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-006276","line_url":"/filing/0001437749-23-006276#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.1463,"price_display":"4.15","price_state":"stated","total_value":20731.5,"total_display":"20,731.50","total_whole":"20,732","shares_owned_after":10835.0,"shares_owned_after_display":"10,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-09","filed_date":"2023-03-13","scope":"insider"},{"id":6748603,"accession":"0001161697-22-000413","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000413","line_url":"/filing/0001161697-22-000413#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":14.159,"price_display":"14.16","price_state":"stated","total_value":283180.0,"total_display":"283,180.00","total_whole":"283,180","shares_owned_after":308207.0,"shares_owned_after_display":"308,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-22","filed_date":"2022-08-23","scope":"insider"},{"id":6897035,"accession":"0001437749-22-013706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-013706","line_url":"/filing/0001437749-22-013706#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":4.39,"price_display":"4.39","price_state":"stated","total_value":8780.0,"total_display":"8,780.00","total_whole":"8,780","shares_owned_after":5835.0,"shares_owned_after_display":"5,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-25","filed_date":"2022-05-26","scope":"insider"},{"id":6422008,"accession":"0001161697-22-000261","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-22-000261","line_url":"/filing/0001161697-22-000261#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":308207.0,"shares_owned_after_display":"308,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-24","scope":"insider"},{"id":5448590,"accession":"0001437749-21-027552","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-027552","line_url":"/filing/0001437749-21-027552#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.789,"price_display":"7.79","price_state":"stated","total_value":15578.0,"total_display":"15,578.00","total_whole":"15,578","shares_owned_after":3835.0,"shares_owned_after_display":"3,835","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-11-30","scope":"insider"},{"id":4858358,"accession":"0001161697-21-000383","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-21-000383","line_url":"/filing/0001161697-21-000383#line-2","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.0779,"price_display":"6.08","price_state":"stated","total_value":303895.0,"total_display":"303,895.00","total_whole":"303,895","shares_owned_after":306874.0,"shares_owned_after_display":"306,874","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-13","filed_date":"2021-08-17","scope":"insider"},{"id":2313165,"accession":"0001437749-20-018283","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-20-018283","line_url":"/filing/0001437749-20-018283","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.653175,"price_display":"0.65","price_state":"stated","total_value":6531.75,"total_display":"6,531.75","total_whole":"6,532","shares_owned_after":28372.0,"shares_owned_after_display":"28,372","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-18","scope":"insider","n_lines":4},{"id":6093085,"accession":"0001104659-18-057805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-057805","line_url":"/filing/0001104659-18-057805#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"BioPharmX Corp","issuer_ticker":"BPMX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director, Officer (CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.2025,"price_display":"0.20","price_state":"stated","total_value":20250.0,"total_display":"20,250.00","total_whole":"20,250","shares_owned_after":7500000.0,"shares_owned_after_display":"7,500,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-19","filed_date":"2018-09-20","scope":"insider"},{"id":5003232,"accession":"0001437749-17-005006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-005006","line_url":"/filing/0001437749-17-005006#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.1999,"price_display":"4.20","price_state":"stated","total_value":4199.9,"total_display":"4,199.90","total_whole":"4,200","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-21","scope":"insider"},{"id":8746760,"accession":"0001209191-15-041652","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-041652","line_url":"/filing/0001209191-15-041652#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"KEMPHARM, INC","issuer_ticker":"KMPH","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":55000.0,"total_display":"55,000.00","total_whole":"55,000","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-21","filed_date":"2015-05-12","scope":"insider"},{"id":5464477,"accession":"0001161697-13-000813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-13-000813","line_url":"/filing/0001161697-13-000813#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8000.0,"shares_display":"8,000","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":16240.0,"total_display":"16,240.00","total_whole":"16,240","shares_owned_after":213401.0,"shares_owned_after_display":"213,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-23","filed_date":"2013-10-25","scope":"insider"},{"id":3180526,"accession":"0001161697-12-000433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-12-000433","line_url":"/filing/0001161697-12-000433#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"CATALYST PHARMACEUTICAL PARTNERS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.5848,"price_display":"0.58","price_state":"stated","total_value":11696.0,"total_display":"11,696.00","total_whole":"11,696","shares_owned_after":205401.0,"shares_owned_after_display":"205,401","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-31","scope":"insider"},{"id":5875667,"accession":"0001161697-09-000253","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-09-000253","line_url":"/filing/0001161697-09-000253#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"Catalyst Pharmaceutical Partners, Inc.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":4650.0,"total_display":"4,650.00","total_whole":"4,650","shares_owned_after":185402.0,"shares_owned_after_display":"185,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-06","filed_date":"2009-03-09","scope":"insider"},{"id":5545162,"accession":"0001209191-06-032682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-032682","line_url":"/filing/0001209191-06-032682#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"Valera Pharmaceuticals Inc","issuer_ticker":"VLRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.73,"price_display":"7.73","price_state":"stated","total_value":7730.0,"total_display":"7,730.00","total_whole":"7,730","shares_owned_after":6500.0,"shares_owned_after_display":"6,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-25","filed_date":"2006-05-25","scope":"insider"},{"id":3572394,"accession":"0001192482-06-000051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-06-000051","line_url":"/filing/0001192482-06-000051#line-1","is_derivative":false,"issuer_cik":"0001292636","issuer_name":"Valera Pharmaceuticals Inc","issuer_ticker":"VLRX","issuer_name_source":null,"issuer_url":"/issuer/0001292636","owner_cik":"0001292636","owner_name":"Tierney David S","owner_display_name":"Tierney David S","owner_url":"/insider/0001292636","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5500.0,"shares_display":"5,500","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":49500.0,"total_display":"49,500.00","total_whole":"49,500","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-02","filed_date":"2006-02-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":15,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Director","n_filings":11,"first_seen":"2009-03-09","last_seen":"2025-08-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Director","n_filings":6,"first_seen":"2015-05-12","last_seen":"2023-03-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001504167","name":"BioPharmX Corp","url":"/issuer/0001504167","role":"Director, Officer (CEO)","n_filings":1,"first_seen":"2018-09-20","last_seen":"2018-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001305409","name":"Valera Pharmaceuticals Inc","url":"/issuer/0001305409","role":"Director, Officer (President and CEO)","n_filings":2,"first_seen":"2006-02-02","last_seen":"2006-05-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001292636","retrieved_at":"2026-08-27T00:03:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}